Court restrains Healing Pharma from selling products over Himalaya trademark dispute

In a major relief to Himalaya Global Holdings Ltd., the Delhi High Court has banned the sale, manufacture, distribution and advertisement of some products of Healing Pharma India Private Limited.

The court observed that the packaging, names and colours of some of the products of Healing Pharma are so similar to those of Himalaya that a common customer may get confused between the two.

Justice AJ Bhambhani issued an interim order in the case on August 18. The matter relates to a dispute over trademark, copyright, and product identity.

Which products are in dispute?

Himalaya had alleged that some of Healing Pharma's products had similar names and packaging to its popular medicines. The products in question included Liverheal, Liverheal 52, Liverheal DS, Senstone, Braintat, Spermax, Pilefine, and Confidence X.

Himalaya said that the packaging and names of these products are similar to its Liv.52, Cystone, Mentat, Speman, Pilex and Confido products.

What did Himalaya allege?

Himalaya told the court that the distinctive packaging, colour combination, design and visual layout of its products have been in use for a long time and have created a distinct identity among the customers.

The company alleged that Healing Pharma used similar names, colors, and packaging designs for its products. Himalaya also alleged passing off, citing trademark and copyright infringement.

Passing Off refers to a situation where a company's product or its packaging is presented in such a way that the customer can associate it with the product of another established company.

Common customers may be confused: Court

The Delhi High Court initially observed that the names, packaging and colours of the products of both the companies were quite similar.

According to the court, a customer with common sense and poor memory may get confused between the two products.

The court stated that Himalaya had established a prima facie case at this stage. The court also recognized that the balance of convenience favored Himalaya and that failure to grant interim relief could cause irreparable harm to the company.

On this basis, the court has stopped Healing Pharma from manufacturing, selling, distributing and advertising these products with the disputed trade dress.

Healing Pharma offered a settlement

During the hearing, Healing Pharma informed the court that it had discontinued the sale of Liverheal 52 effective November 10, 2025, and that the product was now being sold solely under the name Liverheal. The company also expressed its willingness to seek mediation to resolve the dispute through negotiations. Himalaya also agreed to this proposal.

After this, the Delhi High Court has sent both the parties to the Delhi High Court Mediation and Conciliation Centre.

Mediation to be completed within three weeks

Both parties have been directed to appear before the mediation center on August 24, 2026. The court has ordered that the mediation process be completed within three weeks. The next hearing in the case will be scheduled for September 30, 2026. Further proceedings will depend on the outcome of the mediation.

A final decision in this case has not yet been reached. The High Court's interim order is considered important in protecting the packaging and brand identity of Himalaya's products.